Drugs and Interactions Flashcards

(62 cards)

1
Q

Erlotinib target and type

A

EGFR, small molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gefitinib target and type

A

EGFR, small molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cisplatin mechanism? sensitizer?

A

Interstrand cross-links, cell cycle non-specific, inhibits DNA>RNA, radiosensitizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Paclitaxel MOA

A

stabilizes microtubules and protects from disassembly so MITOSIS is blocked and apoptosis is activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vincristine MOA

A

stabilizes microtubules and protects from disassembly so MITOSIS is blocked and apoptosis is activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Docetaxel MOA

A

disrupts microtubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oxygen effect for chemo

A

True for BleOmycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chemos that need hypoxia

A

Mitomycin C

Tirapazamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs that radiosensitize hypoxic cells

A

Misonidazole
Etanodazole
Nimorazole (only clinically used one, in HNSCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cetuximab target and type

A

EGFR tki, mAb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Panitumumab target and type

A

EGFR tki, mAb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sirolimus target

A

mTOR (FRAP1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Everolimus target

A

mTOR (FRAP1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rapamycin target

A

mTOR (FRAP1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bortezomib target

A

proteosome inhibitor (ubiq mediated proteins) in MM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nivolumab target

A

PD1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pembro target

A

PD1 (improved OS/PFS PDL1 expression > 50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Atezolizumab target

A

PDL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Durvalumab target

A

PDL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Avelumab target

A

PDL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ipilimumab

A

CTLA4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Temozolamide sensitive

A

MGMT silencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pemetrexed sensitivity in NSCLC

A

Thymidylate synthase downregulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NER overactivity chemo response

A

cisplatin-resistant (NSCLC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
NER defects (ERCC2 mutated) chemo response
platinum-sensitive
26
HR defects (BRCA1/2) chemo response
platinum-sensitive
27
Infliximab target
TNF-alpha
28
Tipifarnib
RAS (farnesyl transferase)
29
Best radioprotectors
Thiols, need to be in the cell during the radiation Amifostine Sulfydryl They might put an H back on free radicals
30
Imatinib target
BCR-ABL (TKI)
31
Rituxumab target
CD20
32
Vorinostat target
HDAC inhibitor (CTCL)
33
Alectanib target
ALK
34
Wee1 inhibitor target
block G2---> M checkpoint
35
Crizotinib target
ALK, ROS1
36
Trastuzumab/pertuzumab/lapatinib target
HER2
37
Sorafenib target
Raf
38
Vemurafenib
Raf
39
Bromodeoxyuridine MOA
incorp into DNA in place of thymidine during S phase (decrease or removal of shoulder of survival curve); also increased sensitivity to light, radiosensitizer
40
Hsp90 inhibitor
reassortment int G2-M, and other mechs including inhibition of DNA Damage Response, radiosensitizer
41
Radiosensitizers
Taxanes, antiangiogenics, platinums
42
Tirapazamine
bioreductive drug (undergoes reduction to form a cytotoxic species) selectively toxic to hypoxic cells; higher esophagitis SWOG), radiosensitizer
43
Radiation Mitigator (given after exposure
Growth factors/cytokines (keratinocyte growth factor palfermin, G-CSF, IL-11) Antioxidants
44
Other radioprotectors
superoxide dismutase (SOD) (Converts )2 > H2O2 Cysteine WR2721 WR638 (both cover sulfhydryl with phosphate, not useful)
45
Alkylating Agents, other pearl?
"ides" nad "ines": (cyclophosphamide, TMZ, Lomustine, ifosfamide, dacarbazine), CNS penetration (adds alkyl group to guanine, preventing strands of DNA from linking)
46
Antibiotics? Radiosensitizing?
Doxorubicin(Adriamycin) Epirubicin, Mitomycin C, Bleomycin, Daunorubicin, Actinomycin D Very Radiosensitizing
47
anti-Metabolites, Cell cycle-dependent?
"abine" 5FU, gemcitabine, capecitabine, Methotrexate, 6-MP, cytarabine, hydroxyurea Cell cycle - S phase
48
Vinka Alkaloid drugs? cell cycle-dependent?
Vincristine, Vinblastin, Vinorelabine, Vindesin Mitosis No CNS penetration
49
Taxane drugs, cell cycle-dependent? radiosensitizing?
Paclitaxel, Docetaxel, Cabazitaxel Mitosis Radiosensitizing
50
Topoisomerase inhibitors... Cell cycle dependence? radiosensitizing?
Partial S- cycle | not very sensitizing
51
Antibodies cross BBB?
No, too large
52
Tremelumimab target
CTLA4
53
Doxorubicin and Epirubicin MOA?
intercalation and inhibition of DNA biosynthesis; stabilizes topoisomerase II (prevents progression of relaxing supercoils for transcription) thereby preventing replication; most active during S-phase
54
Doxil (liposomal doxorubicin)
preferenetial concentration to skin, designed for Kaposi sarc
55
Irinotecan, Topotecan MOA
Topoisomerase I inhibitor
56
Etoposide
Topoisomerase II inhibitor
57
5FU MOA
pyrimidine antimetabolite, stimulates thymidilate synthase (S-phase)
58
Gemcitabine
antimetabolite, nucleoside analog inhibits ribonucleotide reductase
59
MTX
antimetabolite, inhibits dihydrofolate reductase blocking DNA/RNA synthesis through similarity to folic acid
60
Bleomycin MOA
induction of DNA strand breaks (may also inhibit thymidine incorp in DNA strands) may act via free radicals formed from 02, therefore more tox w/02 (lung tox)
61
Dactinomycin
blocks RNA synthesis/transcription, antibiotics
62
Hydroxyurea
inhibits RNR